9
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The Potential of Selenium in the Treatment of Cancer

Pages 145-156 | Published online: 06 Jul 2009

References

  • Jacobs MM. Selenium inhibition of 1,2-dimethylhydrazine induced colon carcinogenesis. Cancer Res 1983; 43: 16469
  • Arciszewska LK, Martin SE, Milner JA. The antimutagenic effect of selenium on 7,12-dimethyIbenz(a)anthracene and metabolites in the Ames salmonella/microsome system. Biol Trace Elem Res 1982; 4: 259–67
  • Chatterjee M, Banerjee MR. Selenium mediated dose-inhibition of 7,12-dimethylbenz(a)anthracaene induced transformation of mammary cells in organ culture. Cancer Left 1982; 17: 187–95
  • Soullier BK, Wilson PS, Nigro ND. Effect of selenium on azoxymethane-induced intestinal cancer in rats fed high fat diets. Cancer Lett 1981; 12: 343–8
  • Jacobs MM, Griffin AC. Effect of selenium on chemical carcinogenesis. Comparative effects of antioxidants. Biol Trace Elem Res 1979; 1: 1–13
  • Thompson JH, Tagliaferro AR. Effect of selenium on 7,12-dimethylbenz(alpha)-anthracene-induced mammary tumorigenesis (meeting abstract). Fed Proc 1980; 3: 1117
  • Young EO, Milner JA. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by selenium (meeting abstract). Fed Proc 1980; 40: 949
  • Medina D. Selenium mediated inhibition of mouse mammary tumorigenesis (meeting abstract). Proc Am Assoc Cancer Res 1981; 22: 55
  • Thorling EB, Overvad K, Bjerring P, Ebbesen P. The effect of selenium on UV-light induced skin tumors in hairless mice. (meeting abstract) Symposium on Role of Carcinogens and Prompters in Human and Experimental Carcinogenesis. 1983
  • Thorling EB, Overvad K, Bjerring P. Oral selenium inhibits skin reactors to UV-light in hairless mice. Acta Pathol Microbiol Scand 1983; 91: 81–3
  • Thorling EB, Overvad K, Bjerring P. Selenium protects mice against the acute effects of UV-light. (meeting abstract) Twelfth Linderstrom-Lang Conference: Selenium, Glutathione Peroxidase and Vitamin E. 1982, 118
  • Medina D, Lane H, Shepherd F. Effects of selenium on mouse mammary tumorigenesis and glutathione peroxidase activity. Anticancer Res 1981; 1: 377–82
  • Shamberaer RJ, Willis CE. Selenium, zinc and cancer. Nutrition and Cancer, Proceedings of the 18th Annual Meeting of the American College of Nutrition. 1979, 3
  • Milner JA, LeFaivre MH, Grunau JA. The effect of various minerals on the metabolism of 7,12-dimethylbenz(a)anthracene (meeting abstract). Fed Proc 1983; 42: 1313
  • Jansson B. The role of selenium as a cancer-protecting trace element. Metal Ions in Biological Systems. Carcinogenicity and Metal Ions 1980; 10: 281–311
  • Tkeshelashvilli LK, Shearman CW, Zakour RA, Koplitz RM, Loeb LA. Effects of arsenic, selenium and chromium on the fidelity of DNA synthesis. Cancer Res 1980; 40: 2455–60
  • Shamberger RJ. Zinc and other trace substances in the kidneys of patients with cancer and other diseases (meeting abstract). Proc Am Assoc Cancer Res 1982; 23: 75
  • Lane HW, Medina D. Effect of dietary selenium on mammary tumorigenesis and glutathione peroxidase activity in dmba treated mice (meeting abstract). Proc Am Assoc Cancer Res 1983; 23: 387
  • Medina D. Selenium and murine mammary tumorigenesis. Cancer Bull 1982; 34: 162–5
  • Birt DF, Lawson TA, Julius AD, Runice CE, Salmasi S. Inhibition of dietary selenium of colon cancer induced in the rat by bis(2-oxoproyl) nitrosamine. Cancer Res 1982; 42: 4455–9
  • Whanger PD, Schmitz JA, Exon JH. Influence of diet on the effects of selenium in the genesis of mammary tumors. Nutr Cancer 1982; 3: 240–8
  • Marshall MV, Griffith AC. Selenium and cancer chemoprevention (meeting abstract). J Supramol Struct 1981, suppl. 5: 210
  • Schrauzer GN, McGinness JE. Effects of temporary selenium supplementation on the genesis of spontaneous mammary tumors in inbred female C3H/ST mice. Carcinogenesis 1980; 1: 199–201
  • Thompson HJ, Meeker LD, Becci PJ, Kokoska S. Effect of short-term feeding of sodium selenite on 7,12-dimethylbenz(a) anthracene-induced mammary carcinogenesis in the rat. Cancer Res 1982; 42: 49548
  • Ip C. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res 1981; 41: 4386–90
  • Ip C, Ip MM, Kim U. Dietary selenium intake and growth of the MT-W9B transplantable rat mammary tumor. Cancer Lett 1981; 14: 101–7
  • Ip C. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats. Cancer Res 1981; 41: 2683–6
  • Greeder GA, Milner JA. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells. Science 1980; 209: 825–7
  • Watrach AM, Milner JA, Watrach MA. Effect of selenium on growth rate of canine mammary tumor cells in athymic nude mice (meeting abstract). Fed Proc 1980; 40: 949
  • Van Vleet JF, Greenwood LA, Rebar AH. Effect of selenium-vitamin E on hematologic alterations of adriamycin toxicosis in young pigs. Am J Vet Res 1981; 42: 1153–9
  • Prochazkova B, Obrusnik I, Duchon J. Selenium in experimental melanoma. (meeting abstract) Third European Workshop on Melanin Pigmentation. 1981, 128
  • Bruce A. Selenium and tumors. Lakartidningen 1981; 78: 658
  • Banner WP, Tan QH, Zedeck MS. Selenium and the acute effects of the carcinogens, 2-acetylaminofluorene and methylazoxymethanol acetate. Cancer Res 1982; 42: 2985–9
  • Banner WP, Tan QH, Zedeck MS. Studies of the mechanism by which selenium (Se) inhibits tumor formation (meeting abstract). Proc Am Assoc Cancer Res 1981; 22: 115
  • Alexander J, Hostmark AT, Forre O, Von Kraemer BM. The influence of selenium on methyl mercury toxicity in rat hepatoma cells, human embryonic fibroblasts and human lymphocytes in culture. Acta Pharmacol Toxicol (Kbh) 1979; 45: 379–86
  • Danielson KG, Oborn CJ, Medina D. Analysis of presumptive selenium binding proteins from a tumorgenic mouse mammary cell line. (meeting abstract) International Association for Breast Cancer Research. 1983
  • Levander CA. Clinical consequences of low selenium intake and its relationship to vitamin E. Ann NY Acad Sc 1982; 39: 70–82
  • Voit E, Oster O, Collo D, Prellwitz W, Weidauer H. Selenium deficiency in tumor patients. Arch Otorhinolaryngol 1982; 2352/3: 677–8
  • Facchinetti T, Delaini F, Salomona M, Donati MB, Feuerstien S, Wendel A. The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats. Toxicol Lett 1983; 15: 301–7
  • Levander OA. Consequences of low selenium intake by humans and its relationship to vitamin E. (meeting abstract) Twelfth Linderstom-Lang Conference: Selenium, Glutathione Peroxidase and Vitamin E. 1982, 118
  • Lawson T, Birt DF. Enchantment of the repair of carcinogen-induced DNA damage in the hamster pancreas by dietary selenium. Chem Biol Interact 1983; 45: 95–104
  • Lawson T, Birt D. BOP induced damage of pancreas DNA and its repair in hamsters pretreated with selenium (meeting abstract). Proc Am Assoc Cancer Res 1981; 22: 93
  • Russell GR, Nader CJ, Patrick EJ. Induction of DNA repair by some selenium compounds. Cancer Lett 1980; 10: 75–81
  • Chen J, Goetchius MP, Combs GF, Campbell TC. Effects of dietary selenium and vitamin E on covalent binding of aflatoxin to chick liver cell macro-molecules. J Nutrition 1982; 112: 350–5
  • Lewko WM, Winn D, McConnell KP. Effect of sodium selenate on growth and protein synthesis in cultured human breast cancer cells (meeting abstract). Fed Proc 1983; 42: 669
  • Chatterjee M, Banerjee MR. Influence of selenium (Se) and beta-carotene on transformation of mammary cells in culture of the whole mammary organs of balb/c mice. Proc Am Assoc Cancer Res 1983; 23: 349
  • Lalor JH, Llewellyn GC. Biointeraction of sodium selenate and aflatoxin b1 in the Mongolian gerbil. J Toxicol Environ Health 1981; 8: 387–400
  • Rosin MP. Effect of sodium selenite on the frequency of spontaneous mutation of yeast mutator strains (meeting abstract). Proc Am Assoc Cancer Res 1981; 22: 55
  • Gairola C, Chow CK. Dietary selenium, hepatic arylhydrocarbon mydroxylase and mutagenic activation of benzo(a)pyrene, 2-aminoanthracene and 2–amino-fluorine. Toxicol Leu 1982; 11: 281–7
  • Schillanci M, Martin SE, Milner JA. The effects of dietary selenium on the biotransformation of 7,12-dimethylbenz(a)anthracene. Mutat Res 1982; 101: 31–7
  • Martin SE, Adams GH, Schillanci M, Milner JA. Antimutagenic effect of selenium on acridine orange and 7,12-dimethylbenz(a)anthracene in the Ames salmonella/microsomal system. Mutat Res 1981; 82: 41–6
  • Rosin MP. Inhibition of spontaneous mutagenesis in yeast cultures by selenite. selenate and selenide. Cancer Lett 1981; 3: 7–14
  • Medina D, Shepherd F. Selenium-mediated inhibition of mouse mammary tumorgenesis. Cancer Lett 1980; 8: 241–5
  • Wendel A, Reiter R, Hricko HM, Feuerstien S, Blaich G. Modulation of drug metabolism by dietary selenium in the mousehip. (meeting abstract) Twelfth Linderstrom-Lung Conference: Selenium, Glutathione Peroxidase and Vitamin E. 1982, 118
  • Rogers AE, Wetsel WC, Yang S. Endocrine interactions in the nutritional modulation of mammary carcinogenesis in rats. (meeting abstract) Molecular Interrelations of Nutrition and Cancer. 1981, 49
  • Stepanenko VF, Norets TA, Vazilo VE. Selective exposure of thyroid gland follicles to radionuclidesency decaying according to a k-capture model. Radiobiologia 1980; 5: 693–8
  • Medina D, Lane H, Oborn CJ. Uptake and localization of selenium-75 in mammary epithelial cell lines in vitro. Cancer Lett 1982; 15: 301–10
  • Medina D, Miller F, Oborn CJ, Asch BB. Mithichondrial inclusions in selenium-treated mouse mammary ephithelial lines. Cancer Res 1983; 43: 2100–5
  • Prochazkova B, Obrusnik I, Duchon J. Selenium and glutathione peroxidase activity in experimental melanoma. (meeting abstract) Twelfth Linderstrom-Lung Conference: Selenium, Glutathione Peroxidase and Vitamin E. 1982, 118
  • Lo MT, Sandi E. Selenium occurrence in foods and its toxicological significance-a review. J Environ Pathol Toxicol 1980; 4: 193–218
  • Dedov VI, Norents TA. Reaction of the endocrine system of female rats of different age on administration of 75Se-selenomethionine. Med Radiol (Mosk) 1981; 26: 48–52
  • Ip C, Horvath P. Synergenic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats (meeting abstract). Proc Am Assoc Cancer Res 1983; 23: 382
  • Calautti P, Moschini G, Stievano BM, Tomio L, Calzavara F, Perona G. Serum selenium levels in malignant lymphoproliferative diseases. Scand J Haematol 1980; 24: 63–6
  • Ip C, Ip MM. Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. Carcinogenesis 1981; 2: 915–18
  • Thompson HJ, Meeker LD, Becci PJ. Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res 1981; 41: 1413–16
  • Ip C. Interaction of vitamin C and selenium supplementation in the modification of mammary carcinogenesis in rats. 1985; 2, AACR Proceedings
  • Ip C, Sinha DK. Enhancement of mammary tumorgenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake. Cancer Res 1981; 41: 31–4
  • Warzok R, Thust R, Mendel J, Herbst, Eismann C. The influence of sodium selenite on tumor induction by methylnitrosourea (MNU) in rats. Arch Geschwulstforsch 1981; 51: 503–8
  • Worsman MS, Besbris HJ, Cohen AM. Effect of dietary selenium on the interaction between 2-acetylaminofluorene and rat liver DNA in vivo, ‘t’ mice. Cancer Res 1980; 40: 2670–6
  • Medina D, Oborn CJ. Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Lett 1981; 13: 333–44
  • Schrauzer G, White D, Schneider C. Cancer mortality correlation studies. iv. associations of dietary intakes and blood levels of certain trace elements, notably selenium antagonists. Bioinorganic Chemistry 1977; 7: 35–56
  • Schrauzer G. Selenium and cancer. A review. Bioinorganic Chemistry 1975; 5: 275–81
  • Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies. III. Statistical associations with dietary selenium intakes. Bioinorganic Chemistry 1977; 7: 23–34
  • Schrauzer GN, Rhead WJ, Evans GA. Selenium and cancer: chemical interpretation of a plasma ‘cancer test’. Bioinorganic Chemistry 1973; 2: 32940
  • Schrauzer GN, White DA. Selenium in human nutrition: dietary intakes and effects of supplementation. Bioinorganic Chemistry 1978; 8: 303–18
  • Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983; 2: 130–4
  • McConnell KP, Jager RM, Bland KI, Blotcky AJ. The relationship of dietary selenium and breast cancer. J Surg Oncol, 15: 67–70
  • Broghamer WL, McConnell KP, Grimaldi M, Blotcky AJ. Serum selenium levels in carcinoma and reticulo-endothelial neoplasms. Nutrition and Cancer, Proceedings of the 18th Annual Meeting of the American College of Nutrition 1979; 3: 297
  • McConnell KP, Jagar RM, Higgins PJ, Blotchy AJ. Serum selenium levels in patients with and without breast cancer. Nutrition and Cancer, Proceedings of the 18th Annual Meeting of the American College of Nutrition 1979; 3: 297
  • Goodwin WJ, Lane HW, Bradford K, et al. Selenium and glutathione peroxidase levels in patients with epidermoid carcinoma of the oral cavity and oropharynx, ‘t’. Cancer 1983; 51: 110–15
  • Revici E. Research in physiopathology as basis of guided chemotherapy: with special application to cancer. Van Nostrand, New York 1961
  • Ashby BS, Cantab MB. pH studies in human malignant tumors. Lancet 1966; 2: 312–15
  • Sculier JP, Nicaise C, Klastersky J. Lactic acidosis: a metabolic complication of extensive metastatic cancer. Eur J Cancer Clin Oncol 1983; 19: 597–601
  • Raju RN, Kardinal CG. Lactic acidosis in lung cancer. Southern Med J 1983; 76: 397–8
  • Leyden M, Sullivan J, Szer J, Brodie G. Fatal lactic acidosis in lymphoma-a report of two cases. Aust NZ J Med 1983; 13: 179–80
  • Raymond Brown M. D. State of New York Department of Health Board for Professional Medical Conduct in the Matter of Emanuel Revici. May 16, 1984; 1609, Letter from Gerald Murphy, Director of Roswell Park Memorial Institute to Dr. Ray Brown dated March 4, 1976
  • Cavalieri RR, Scott KG. Sodium selenite Se 75: a more specific agent for scanning tumors. JAMA 1968; 206: 591–5
  • Cavalieri RR, Scott KG, Sairenji E. Selenite (75 Se) as a tumor-localizing agent in man. J Nuclear Med 1966; 7: 197–208
  • Spencer RP, Montana G, Scanlon GT, Evans OR. Uptake of selenomethionine by mouse and in human lymphomas, with observations on selenite and selenate. J Nuclear Med 1967; 8: 197–208
  • Select Committee on Crime, 92nd Congress, Part I. U. S. Govt. Printing Office. April 26–28, 1971; 273–322
  • Ravich RA. Revici method of cancer control: evaluation of 1047 patients with advanced malignancies treated from 1946–1955. 1955, (Unpublished Manuscript Prepared at the Request of John Heller, former Director of NCI and Sloan Kettering)
  • , Letter from Department of Health and Human Services, April 26, 1984. Biographical note on Professor Maisin from the Belgian Government Information Center
  • , Letter from Professor J. Maisin to Emanuel Revici M.D. dated February 26, 1965. Letter and translation available from Author
  • , Letter from Professor J. Maisin to Emanuel Revici M.D. dated November II, 1969. Letter and translation available from Author
  • Respondent's Exhibits K, L, and M, State of New York Department of Health State Board for Professional Conduct in the Matter of Emanuel Revici. 1983; 829–830, Discussion
  • Montegazza P. Attivita antitumorale di un composto in fase sperimentale. Universita Degli Studi, Dipartimento Di Pharmacologia, Chemoterapia E Tossicologia Medica, Milano April 13, 1984; 20129
  • Pacelli E. Naples Study: report on the use of revici method of the treatment of cancer patients with an average prognosis of 80 days to live. April, 1984, Manuscript in progress
  • Jones TH. Toxicity of selenium, June 1970-June 1980. National Technical Information, Springfield, Va 1980; 74, Citations From the NTIS Data Base. As PB80–852700. NERACUSGNT0419
  • Wilber CG. Toxicology of selenium: a review. Clin Toxicol 1980; 17: 171–230
  • Buell DN. Potential hazards of selenium as a chemopreventive agent. Seminars in Oncology 1983; 19: 311–20
  • Testimony of G. Schrauzer in the Matter of E. Revici. January 30, 1985
  • Whiting RF, Wei L, Stich HF. Unscheduled DNA synthesis and chromosome aberrations induced by inorganic and organic selenium compounds in the presence of glutathione. Mutat Res 1980; 78: 159–69
  • Schrauzer G. Selenium and cancer: historical developments and perspectives, M Spallholz, G Spallholz. Avi Publishing Company, Westport 1981
  • Schwartz K, Pathak K. The biological essentiality of selenium, and the development of biologically active organaselenium compounds of minimum toxicity. Chemica Scripta 1975; 8A: 85–95
  • Kuhn TS. The structure of scientific revolutions. Foundation of the Unity of Science. University of Chicago Press, Chicago 1970; vol II
  • Crisp Report Format F. Selenium. National Institute of Health. 1984

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.